Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Irbesartan with diuretic
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Irbesartan 300mg / Hydrochlorothiazide 12.5mg tablets
0205052A0AAABAB
|
Irbesartan/hydchlorothiazide | Irbesartan with diuretic | Cardiovascular System | 5,600 |
|
Irbesartan 150mg / Hydrochlorothiazide 12.5mg tablets
0205052A0AAAAAA
|
Irbesartan/hydchlorothiazide | Irbesartan with diuretic | Cardiovascular System | 4,520 |
|
Irbesartan 300mg / Hydrochlorothiazide 25mg tablets
0205052A0AAACAC
|
Irbesartan/hydchlorothiazide | Irbesartan with diuretic | Cardiovascular System | 3,212 |
|
CoAprovel 300mg/12.5mg tablets
0205052A0BBABAB
|
Coaprovel | Irbesartan with diuretic | Cardiovascular System | 1,816 |
|
CoAprovel 150mg/12.5mg tablets
0205052A0BBAAAA
|
Coaprovel | Irbesartan with diuretic | Cardiovascular System | 831 |
|
CoAprovel 300mg/25mg tablets
0205052A0BBACAC
|
Coaprovel | Irbesartan with diuretic | Cardiovascular System | 168 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.